The bwi product analysis lab received the device for evaluation on 09-apr-2022.The device evaluation was completed on 29-apr-2022.The device was returned to bwi for evaluation.Bwi conducted a visual inspection and failure analysis on the returned device.Visual analysis of the returned sample revealed a cut on the pebax with reddish-brown material inside and internal parts exposed; however, the cut could be related to the handling since in the process there are control inspection points to avoid this kind of issue.Then the catheter was connected to the carto 3 system and was recognized and the hi error was visualized.For this finding, the test was unable to be performed.The evaluation determined that the cause of pebax damage failure cannot be established.However, the blood found inside the pebax area may have contributed to the hi error displayed on the carto 3 system.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.As part of bwi¿s quality process, all devices are manufactured, inspected, and released to approved specifications.It should be noted that product failure is multifactorial.The instructions for use contain the following warning stated in the carto 3 system manual: -for force issues, the catheter is disconnected.To continue, replace the catheter cable.If that does not resolve the problem, replace the catheter manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent an idiopathic ventricular tachycardia (idvt) procedure with a thermocool® smart touch® sf bi-directional navigation catheter and the biosense webster, inc.Product analysis lab observed a cut on the pebax with internal parts exposed.Initially it was reported that the carto 3 system had high force readings upon ablation starting.The catheter cable was replaced and the issue did not resolve.The catheter was replaced and the issue resolved.Case continued.There was no patient consequence reported.The high force issue was assessed as not mdr reportable.The issue was highly detectable when occurring.The potential that it could cause or contribute to a death, serious injury, or other significant adverse event was low.The biosense webster, inc.Product analysis lab received the device for evaluation and per the evaluation completion on 29-apr-2022 there was a cut on the pebax with reddish-brown material inside and internal parts exposed.The cut on the pebax with internal parts exposed was assessed as mdr reportable.The awareness date for this reportable lab finding was 29-apr-2022.
|